BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S, Noguchi Y. Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer. 1999;79:1145-1150. [PMID: 10098749 DOI: 10.1038/sj.bjc.6690182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev. 2009;29:903-953. [PMID: 19434693 DOI: 10.1002/med.20159] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 10.7] [Reference Citation Analysis]
2 Pan F, Ren JG, Zhou CW, Zhang ZY, Zhao JN, Zhou XR. Correlation of platelet-derived endothelial cell growth factor/ thymidine phosphorylase and Cox-2 expression to angiogenesis and apoptosis in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2004; 12(6): 1268-1272 [DOI: 10.11569/wcjd.v12.i6.1268] [Reference Citation Analysis]
3 Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535. [PMID: 11159189 DOI: 10.1016/s0002-9440(10)63994-6] [Cited by in Crossref: 343] [Cited by in F6Publishing: 145] [Article Influence: 16.3] [Reference Citation Analysis]
4 Nie X, Bhat R, Al-Saleem ED, Vonderheid EC, Hou JS. Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome. Adv Hematol 2011;2011:875135. [PMID: 22162690 DOI: 10.1155/2011/875135] [Reference Citation Analysis]
5 Bijnsdorp IV, Capriotti F, Kruyt FA, Losekoot N, Fukushima M, Griffioen AW, Thijssen VL, Peters GJ. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer 2011;104:1185-92. [PMID: 21386840 DOI: 10.1038/bjc.2011.74] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
6 Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, Misawa K, Hirao M, Yoshida K, Oki E, Sasako M, Emi Y, Bando H, Kawashima Y, Fukunaga T, Gotoh M, Ishibashi T, Shitara K. Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy. Ann Surg Oncol 2019;26:465-72. [PMID: 30456678 DOI: 10.1245/s10434-018-7063-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
7 Braybrooke JP, Propper DJ, O'Byrne KJ, Koukourakis MI, Patterson AV, Houlbrook S, Love SD, Varcoe S, Taylor M, Ganesan TS, Talbot DC, Harris AL. Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha. Br J Cancer 2000;83:219-24. [PMID: 10901374 DOI: 10.1054/bjoc.2000.1230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
8 Ezaki T, Ikegami T, Maeda T, Yamada T, Ishida T, Hashizume M, Maehara Y. Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma. Int J Clin Oncol. 2005;10:171-176. [PMID: 15990964 DOI: 10.1007/s10147-005-0488-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
9 Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
10 Ezaki T, Ikegami T, Ishida T, Aimitsu S, Mori M, Fujihara M. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence. J Surg Oncol. 2003;83:173-19; discussion 179. [PMID: 12827687 DOI: 10.1002/jso.10259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kobayashi M, Okamoto K, Akimori T, Tochika N, Yoshimoto T, Okabayashi T, Sugimoto T, Araki K. Localization of thymidine phosphorylase in advanced gastric and colorectal cancer. J Mol Histol 2004;35:69-74. [PMID: 15323351 DOI: 10.1023/b:hijo.0000021086.09680.4f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Wang L, Huang X, Chen Y, Jin X, Li Q, Yi TN. Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma. Eur J Surg Oncol. 2012;38:568-573. [PMID: 22595739 DOI: 10.1016/j.ejso.2012.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
13 Warfield BM, Matheson CJ, McArthur DG, Backos DS, Reigan P. Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation. ACS Chem Neurosci 2021;12:3477-86. [PMID: 34472849 DOI: 10.1021/acschemneuro.1c00494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]